Replimune

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Replimune and other ETFs, options, and stocks.

About REPL

Replimune Group, Inc. is a clinical-stage biotechnology company, which engages in the development of oncolytic immunotherapy product candidates through immulytic platform. Its product candidates include RP1, RP2, and RP3. 

CEO
Philip Astley-Sparke
CEOPhilip Astley-Sparke
Employees
206
Employees206
Headquarters
Woburn, Massachusetts
HeadquartersWoburn, Massachusetts
Founded
2015
Founded2015
Employees
206
Employees206

REPL Key Statistics

Market cap
1.29B
Market cap1.29B
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
503.63K
Average volume503.63K
High today
$26.41
High today$26.41
Low today
$25.64
Low today$25.64
Open price
$25.98
Open price$25.98
Volume
354.49K
Volume354.49K
52 Week high
$29.41
52 Week high$29.41
52 Week low
$13.05
52 Week low$13.05

Analyst ratings

100%

of 9 ratings
Buy
100%
Hold
0%
Sell
0%

REPL Earnings

-$0.79
-$0.53
-$0.26
$0.00
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Q1 FY23
Q2 FY23
Q3 FY23
Estimated
-$0.75 per share
Estimated-$0.75 per share
Actual
Expected Feb 10, Pre-Market
ActualExpected Feb 10, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.